50% off Premium Yearly

CVE:LND
Provides financing for doctors. US doctors are having cash flow problems, in that their receivables coming from Medicare are taking a lot longer than they had in the past. This company gets paid by Medicare and they finance the doctors’ receivables. A great business. Expects they will make further acquisitions. Pretty cheap at this time.
Does cash flow loans to doctors in the US. Have grown their loan book from a standing start 9 months ago to more than $40 million. Thinks it will be a rollup and there will be some acquisitions made. Fairly cheap and they have a lot of cash on the books right now. Management has said they can take their loan book to $500 million without raising any stock.
It is a lender. It lends to doctors and provides credit to doctors. Because of the change in the way Medicare is funded in the US, patients are now more responsible for paying their medical bills. As patients are slower in paying for their medical services, Inspira funds that gap. .He thinks it will be fine. They have a lot of cash and have raised a lot of money. It should bounce back. They have a healthy cash balance and a good business plan.
The loan book 7 months ago was about $300,000, and now it is $30 million. A very rapid growth story. Essentially they are loaning money to doctors against Medicare receivables. With the change in the affordable care act, doctors need more working capital, because they are collecting more of their fee from patients, and are getting delayed on when they get their money from Medicare. Healthcare is 20% of the US economy. This has lots of room to grow.